15. SCa < 8.5 mg/dl
SPi < 3.5 mg/dl SPi > 3.5 mg/dl
FECa
Renal loss
25(OH)D↓
VD deficiency
25(OH)D: N/1,25(OH)2D↓
VD dependent rickets: Type I
25(OH)D: N/1,25(OH)2D↑
VD dependent rickets: Type II
High
Low
GFR
PTH
Mg
Low
Low N/↑
Pseudo-hypo-
parathyroidism
Low
N
Primary/Secondary
hypoparathyroidism
Mg related
hypoparathyroidims
CRF
16. FE of electolyteFE of electolyte
FE of K >6.5%→ renal K wasting in hypoK
FE of Pi >5.0% → renal Pi wasting in hypoPi
FE of Mg>2.5%→ renal Mg wasting
in hypoMg
FE of Na> 1.0% → renal Na wasting
in hypoNa
FE of Ca>3.0% → renal Ca wasting
in hypoCa
17. Hypocalcemia: causesHypocalcemia: causes
Loss of circulating free calcium:
extravascular deposition: hyperphosphatemia; renal
failure; acute pancreatitis; osteoblastic metastasis;
hyngry bones syndrome
intravascular binding: citrate, lactate, foscarnet,
EDTA, acute respiratory alkalosis(↑Ca-albumin)
Hypoparathyroidism: S/P
PTX, thyroidectomy, or radical neck surgery
pseudohypoparathyroidism; idiopathic
Hypomagnesemia; severe hypermagnesemia
Vitamin D deficiency
18.
19. Hungry bones syndromeHungry bones syndrome
Severe form:
Profound hypocalcemia+↓Mg+↓Pi :
S/P PTX for severe osteodystrophy
Mild form:
S/P thyrotoxicosis
accelerated bone formation in leukemia
osteoblastic metastasis
early healing of rickets or osteomalacia
Calcitriol: 2 ~ 3μg/D(initial dose) with rapid
reduction after normocalcemia
20.
21. Hypocalcemia in acuteHypocalcemia in acute
pancreatitispancreatitis
Extravascular deposition
Glucagon-stimulated calcitonin release
Inadequate PTH secretion
22.
23. HypoparathyroidismHypoparathyroidism
S/P OP: permanent or intermittent
Hypomagnesemia(SMg<1mg/dl) in
malabsorption or chronic alcoholism
Severe hypermagnesemia in toxemia of
pregnancy( SMg> 6mg/dl)
Pseudo type1: Ia(AD, G-protein) Ib(↓receptor)
Pseudo type II: ↓cAMP-dependent PK
24.
25. Vitamin D deficiencyVitamin D deficiency
Reduced VD intake or production:
bedridden state(no sun exposure)
steatorrhea or malabsorption
Reduced availability of calcifediol(hepatic):
severe liver disease
use of Dilantin/phenobarbital
nephrotic syndrome(↓VD binding protein)
Reduced production of calcitriol(renal):
chronic renal failure
VD-dependent ricket
26.
27. Hypocalcemia in sepsisHypocalcemia in sepsis
Inadequate PTH or end-organ resistance
Inadequate VD
Hypomagnesemia
Glucagon-induced calcitonin release
28.
29. Principles of treatmentPrinciples of treatment
Symptomatic hypocalcemia – emergency
10 ml of 10% calcium gluconate IV over 10
minutes.
Iv calcium should not be given with bicarbonate
or phosphate containing solution
Serial calcium measurements
Correction of co-existing alkalosis
Calcium suppy in long term
30. IV calcium supplyIV calcium supply
Symptomatic hypocalcemia (Sca<5.6mg/dl) :
heart failure, hypotention, bradycardia
convulsions, tetany,
paresthesias
1 ~ 2 ampules(90mg/A), 10% Ca gluconate in 5
~ 10ml, 5% dextrose, IVF for 5 ~ 10minutes
10 ampules, Ca gluconate in 1L, 5%
dextrose, IVF: 50ml/Hr ( 45mg,calcium/Hr)
Calcium dose: 15mg/Kg IVF for 6 hr
Calcium space: 50 ~ 75%(?)
31. Adjuvant therapyAdjuvant therapy
Magnesium supply:
Hypocalcemia+Normal renal function+Normal
DTR
10% MgSo4, 2G, IVF for 10 minutes
10% MgSo4, 1G/100cc,fluid/Hr
Oral calcium and calcitriol( 0.5 ~ 1.0μg/D)
should initiated early
32. PO calcium supplyPO calcium supply
Calcium: 2 ~ 4G/D
Vitamin D indicated if insufficient response
33. PO Calcium preparationPO Calcium preparation
mg/Tb Ca,mg/Tb
CaCO3 500 200( 40% )
Ca gluconate 1000 90( 8% )
Ca lactate 300 60( 12% )
34. Things to rememberThings to remember
– Treat the patient, not the lab valueTreat the patient, not the lab value
– Rate of correction should mirror rate of changeRate of correction should mirror rate of change
– Correct in orderly fashionCorrect in orderly fashion
1. Volume1. Volume
2. pH2. pH
3. Potassium, Calcium, Magnesium3. Potassium, Calcium, Magnesium
4. Sodium and Chloride4. Sodium and Chloride
– Consider impact of interventions overallConsider impact of interventions overall
35.
36. Calcium handling in kidneyCalcium handling in kidney
PCT: 60 ~ 65% of filtrate by para-cellular path
THAL: 20% of filtrate by para-cellular path
paracellin-1 for Mg&Ca reabsortion
Simon et al, Science 1999
DN: 10 ~ 15% by trans-cellular pathway
ECaC1, apical: VD ↑; lower pH ↓
Calbindin-D 28k: VD ↑;
estrogen↑; CsA↓
NCX1,basolateral: 70%
PMCA1b,basolateral: 30%
Cl channel: PTH, Thiazide
37.
38. TRPV5 cell surface abundanceTRPV5 cell surface abundance
Factors Cell surface abundance Proposed mode of action
Klotho + Modification channel glycosylation
Tissue kallikrein + PKC mediated channel phosphorylation
Acid pH - Dynamic plasma membrane trafficking
Ca - Channel recycling
Mg ND NA
PIP2 ND NA
WNK4 + ND (familial hyperkalemic
HTN/hypercalciuria)
ND: not determined; NA: not applicable
+, increase; -, decrease; =, no effect
WNK, With-No-Lysine(K): serine/threonine protein kinases
39. TRPV5 single channel activityTRPV5 single channel activity
Factors Single channel activity Proposed mode of action
Klotho ND NA
Tissue kallikrein ND NA
Acid pH - Proton binding to channel pH sensors
Ca - Feedback inhibition via channel C tail
Mg - Conformational change channel via
Mg binding
PIP2 + Stabilization channel open conformation
WNK4 =
ND: not determined; NA: not applicable
Kloth: anti-aging hormone
41. ECaC1 homologuesECaC1 homologues
Muller et al, NDT 2001Muller et al, NDT 2001
Sequence
similarities
tissue
distribution
Chromosome
7q35
hECaC1 80% Kidney>GI Evolution
gene
duplication
hCaT1 80% GI>kidney hECaC2
42. TRP V 5 knockout mice modelTRP V 5 knockout mice model
Transient receptor potential channels (TRP): Gate-keeper
proteins
TRP V5 in kidney: ECaC 1
TRP V6
Hypercalciuria
Diuresis: CaSR, apical in principal cells + Ca in lumen ﹡
→AQP2
Acid urine: CaSR, apical in intercalated cells + Ca in
lumen → H+APTase
Hyperphosphaturia
Rene Bindels: Radboud University Nijmegen Medical Center,
Netherlands
43.
44. Hypercalciuric stone disease: XLHypercalciuric stone disease: XL
O Devuyst and Y Prison: KI 2008(Belgium)O Devuyst and Y Prison: KI 2008(Belgium)
Dent’s disease:
CLCN5/CLC-5/ Cl/H exchanger
PT/TAL/IC α
Renal:
Trafficking defect: endocytosis
PT dysfunction: Fanconi syndrome
Nephrocalcinosis, stones
Impaired urine acidification
Renal failure
Extra-renal:
Rickets
Lowe’s disease
OCRL/OCRL1/
Phosphatidylinositol 4,5-
biphosphate 5-phosphatase
PT
Renal:
PT dysfunction: Fanconi syndrome
Proximal RTA
Nephrocalcinosis, stones
Extra-renal:
Mental retardation, growth delay
Cataract, rickets, cryptorchidism
Neuromuscular/behavior
abnormality
45. Hypercalciuric stone disease: ADHypercalciuric stone disease: AD
O Devuyst and Y Prison: KI 2008(Belgium)O Devuyst and Y Prison: KI 2008(Belgium)
AD Hypocalcemia
( Bartter syndrome V)
CASR/CaSR/ calcium sensing
receptor
PT/TAL/DCT/CD
Renal: gain-of-function
Low serum PTH
Hypocalcemia, Hypercalciuria
Nephrocalcinosis, stones
Salt-losing nephropathy;
Hypokalemia (CaSR→ ROMK↓)
Extra-renal: basal ganglia
calcifications, seizures
Distal RTA (RTA I)
SLC4A1/ AE1/ Cl/HCO3
exchanger
ICα
Renal:
Impaired anion exchange in IC α
Metabolic acidosis
Hypercalciuria
Nephrocalcinosis, stones
Extra-renal:
Osteomalacia, rickets
Growth retardation
46. Hypercalciuric stone disease; ARHypercalciuric stone disease; AR
O Devuyst and Y Prison: KI 2008(Belgium)O Devuyst and Y Prison: KI 2008(Belgium)
Ante-natal Bartter’s syndrome I: NKCC2/ Na-K-2Cl
cotransporter 2
Hyperprostaglandin E syndrome
Ante-nasal Bartter’s syndrome II: ROML/ K channel
Hyperpostagladin E syndrome
2
Bartter’s syndrome III: CLC-Kb/ Cl channel
Familial hypomagnesemia with hypercalciuria and
nephrocalcinosis: FHHNC
Distal RTA with progressive nerve deafness: ATP6V1B1/
B1 subunits of proton pump
Distal RTA with preserved hearing/late onset hearing loss:
ATP6V0A4 / A4 subunits of proton pump
47. FHHNCFHHNC
CLND 16/ Claudin-16/ paracellin-1 tight junction
protein
TAL, DCT
Renal:
Impaired paracellular transport of Ca/Mg:
calcium and magnesium wasting
Nephrocalcinosis, stones
Renal failure
Extra-renal:
Convulsions, tetany, chondrocalcinosis,
neuro-muscluar manifestations
48. Function of CIC 5: Cl/H exchangerFunction of CIC 5: Cl/H exchanger
PT cell
Coated
vesicle
Recycling
endosome
LMW
H+ Cl/H
CLLate endosome
Lysosome
49. Functional loss of ClC-5Functional loss of ClC-5
Trafficking defect in PT cells
Generalized PT cell dysfunction-Renal
Fanconi syndrome
LMW proteinuria: DBP-25(OH)D3; PTH
Internalization of NaPi-IIa: phosphaturia
↑1 α hydroxylase: ↑1,25(OH)2D3
Hypercalciuria, nephrocalcinosis, stones
Editor's Notes
In presence of albumin, total Ca may be low but ionized Ca remains normal
Vit D deficiency
Sunlight/dietary deficiency
Malabsorption (Gastrectomy)
Chvostek – Twitch at corner of mouth when tapped over facial nerve just in front of ear.
Trosseau – Carpal spasm produced when BP cuff to upper arm maintains a pressure above systolic for 3 min.
Fingers spastically extend at the IP joints and flex at the MCP joints. Wrist flexed, forearm pronated,